Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • BIAL

    Applying Vibrotactile Stimulation to Improve Parkinson’s

    Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

    Impetus Digital

    Applying Vibrotactile Stimulation to Improve Parkinson’s

    Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

    Impetus Digital

    Cannes Lion 2022

    Our Top 5 Pharma Picks From Cannes Lions

    Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022.

    The Good Ideas Group

    Applying Vibrotactile Stimulation to Improve Parkinson’s

    Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how innovative medical devices and software can improve...

    Impetus Digital

    - PMLiVE

    Intec sounds a sad note as Accordion Parkinson’s trial fails

    Intec’s lifeline now is Novartis partnership

    - PMLiVE

    AmyPore gets EU backing for Alzheimer’s and Parkinson’s therapy

    Novel chimeric peptide ready to start clinical trials

    - PMLiVE

    Theranexus takes Alzheimer’s drug combo into clinic

    150-subject phase 1b trial to start at eight centres in France

    - PMLiVE

    Smart watch epilepsy monitor cleared by FDA

    Approval could potentially clear the way for insurers to reimburse its cost

    - PMLiVE

    Pfizer and IBM’s tech-enabled ‘Parkinson’s house’

    Pharma firm looks to technology to help it unlock the doors to breakthrough treatments

    - PMLiVE

    Bial launches video campaign for World Parkinson’s Day

    Aims to challenge negative portrayals of people with the disease

    EU flag

    EU proposes reforms to make first-in-human trials safer

    New guideline revision paper “takes into account lessons learnt” from fatal Bial trial

    EU flag

    EC approves Bial’s Parkinson’s disease therapy

    Ongentys will be given a phase roll-out in 2016 and 2017

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links